NDC 63323-569-84 Enoxaparin Sodium

Enoxaparin Sodium

NDC Package Code 63323-569-84

The NDC Code 63323-569-84 is assigned to a package of 10 syringe in 1 carton > 1 ml in 1 syringe of Enoxaparin Sodium, a human prescription drug labeled by Fresenius Kabi Usa, Llc. The product's dosage form is injection and is administered via subcutaneous form.

Field Name Field Value
NDC Code 63323-569-84
Package Description 10 SYRINGE in 1 CARTON > 1 mL in 1 SYRINGE
Proprietary Name Enoxaparin Sodium What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Enoxaparin Sodium What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
11-Digit NDC Billing Format 63323056984 NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.
Billing Unit ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Product Type Human Prescription Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Labeler Name Fresenius Kabi Usa, Llc
Dosage Form Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s)
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
  • ENOXAPARIN SODIUM 150 mg/mL
  • ENOXAPARIN SODIUM 150 mg/mL
Pharmacological Class(es)
  • Heparin -
  • Low-Molecular-Weight - [CS]
  • Low Molecular Weight Heparin - [EPC] (Established Pharmacologic Class)
  • Heparin -
  • Low-Molecular-Weight - [CS]
  • Low Molecular Weight Heparin - [EPC] (Established Pharmacologic Class)
Sample Package No Sample Package?
This field Indicates whether this package is a sample packaging or not.
Marketing Category NDA AUTHORIZED GENERIC - A product marketed as a “generic” drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
FDA Application Number NDA020164 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Start Marketing Date 02-20-2015 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
Listing Expiration Date 12-31-2020 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

NDC Code Structure

  • 63323 - Fresenius Kabi Usa, Llc
    • 63323-569 - Enoxaparin Sodium
      • 63323-569-84 - 10 SYRINGE in 1 CARTON

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

NDC HCPCS Crosswalk

This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

NDC 63323-569-84 HCPCS crosswalk information with package details and bill units information.

NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
63323056984J1650Inj enoxaparin sodium10 MG11015150

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for Enoxaparin Sodium with product NDC 63323-569.

NDC Package CodePackage Description
63323-569-9010 SYRINGE in 1 CARTON > .8 mL in 1 SYRINGE
63323-569-9510 SYRINGE in 1 CARTON > 1 mL in 1 SYRINGE
63323-569-9910 SYRINGE in 1 CARTON > .8 mL in 1 SYRINGE

* Please review the disclaimer below.

Previous Code
63323-569
Next Code
63323-572